It was reported in a vascular surgery presentation in (b)(6) titled "(b)(6)" a supera stent was implanted in the superficial femoral artery on (b)(6) 2018.Then on (b)(6) 2019, the patient was feeling symptomatic with limb ischemia and then thrombus 10mm distal and proximal to the implanted supera stent (not inside the supera) was identified.It was decided to do a laser atherectomy in the proximal and distal part to treat it.The patient had good result.However, it was noted that 10mm proximal to the supera stent there was a dissection of the artery.Another supera stent was used to treat the dissection.Per the physician, this was caused by the patients history with thrombophilia and not by the supera stent.Additionally, the physician states that the thrombus plaque noted was from not being treated in (b)(6) 2018.No additional information was provided.
|
Date of event: estimated date of event.The udi is unknown because the part and lot numbers were not provided.The device was not returned for analysis.The lot history record (lhr) for this product could not be reviewed because the product was not returned for evaluation and the part and lot numbers were not reported.The reported patient effect of thrombosis is listed in the supera instructions for use as a known potential patient effect associated with the use of the device.Based on the case information, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling; therefore, no corrective action is required.
|